ArticleEndoscopy international open2018
Comparative analysis of ESD versus EMR in a large European series of non-ampullary superficial duodenal tumors.
Article in Endoscopy international open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 55 citations in OpenAlex.
- Endoscopic Resection for Non‑ampullary Duodenal Lesions: 13 Years of Experience from a Large Tertiary Center in China.Digestive diseases and sciences · 2026Observational
- Clinical practice guidelines for duodenal cancer 2025.Journal of gastroenterology · 2026Review
- Outpatient endoscopic submucosal dissection for non-ampullary duodenal lesions: a single-center experience at a U.S. tertiary referral center.Surgical endoscopy · 2026Article
- Reducing post-endoscopic submucosal dissection pancreatitis in periampullary duodenal lesions: the role of prophylactic pancreatic duct stenting.Clinical endoscopy · 2026Article
- Endoscopic Resection for Superficial Non-Ampullary Duodenal Epithelial Tumors.Gut and liver · 2025Review
- Endoscopic diagnosis and treatment of superficial non-ampullary duodenal epithelial tumors: A review.Journal of translational internal medicine · 2023Article
- [Interventional endoscopy in gastroenterology].Innere Medizin (Heidelberg, Germany) · 2023Article
- Outcomes of endoscopic mucosal resection for large superficial non-ampullary duodenal adenomas.Scientific reports · 2022Article
- Endoscopic submucosal dissection in the duodenum: Ready for prime time?Endoscopy international open · 2022Article
- Endoscopic management of NADTs.Endoscopy international open · 2022Article
- The Use of Endoscopic Clipping in Preventing Delayed Complications after Endoscopic Resection for Superficial Non-Ampullary Duodenal Tumors.Clinical endoscopy · 2021Article
- Endoscopic Treatment for Superficial Nonampullary Duodenal Tumors.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2021Review
- [Interventional endoscopy in the gastrointestinal tract : Indications and limitations].Der Internist · 2020Article
- Endoscopic mucosal resectionWorld journal of gastrointestinal oncology · 2020Article
- Pathologic Evaluation of Endoscopically Resected Non-Ampullary Duodenal Lesions: A Single Center Experience.Turk patoloji dergisi · 2020Article
- ESD versus EMR in non-ampullary superficial duodenal tumors: a systematic review and meta-analysis.Endoscopy international open · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND STUDY
aimsThe choice of endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR) in non-ampullary superficial duodenal tumors (NASDTs) is challenging and the benefits of ESD remain unclear. The aim was to comparatively analyze the feasibility, outcomes and safety of these techniques in these lesions. PATIENTS AND
methodsThis is an observational and retrospective study. All consecutive patients presenting with NASDTs who underwent EMR or ESD between 2005 and 2017 were included. The following main outcomes were comparatively evaluated: en-bloc and complete (R0) resection rates, and local recurrence. Secondary outcomes were perforation and delayed bleeding.
resultsOne hundred sixty-six tumors in 150 patients (age: 66 years, range: 31 - 83, 42.7 % males) were resected by ESD (n = 37) or EMR (n = 129) and included. The median procedure time (81 vs. 50 min,
conclusionsESD may be an alternative to EMR and surgery in selected NASDTs, such as large duodenal tumors where EMR achieves low en-bloc resection rates and the local recurrence may be higher. However, this technique may have a higher risk of perforations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.